As irisin functions to promote the browning of the white adipose tissue, to improve insulin sensitivity in insulin-resistant states, and to protect functional integrity of the vascular endothelium, its deficiency in the fetoplacental circulation may therefore amplify the susceptibility of growth-retarded neonates to the later development of metabolic syndrome. Here, FNDC5 is linked to metabolic syndrome.